We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Aerie Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 153 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 156 → 0 (-156)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $703M → $0 (-$703M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 153

Holders
–
Holders Change
-156
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
153
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$73.5M
2
BlackRock
BlackRock
New York
-$53.6M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$36.9M
4
UBS Group
UBS Group
Switzerland
-$36.4M
5
WIC
Water Island Capital
New York
-$31.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
101
Invesco
Georgia
– -$318K -21,023 Closed
BWP
102
BSW Wealth Partners
Colorado
– -$314K -20,750 Closed
Manulife (Manufacturers Life Insurance)
103
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$297K -19,618 Closed
State Board of Administration of Florida Retirement System
104
State Board of Administration of Florida Retirement System
Florida
– -$297K -19,597 Closed
Legal & General Group
105
Legal & General Group
United Kingdom
– -$289K -19,147 Closed
VOYA Investment Management
106
VOYA Investment Management
Georgia
– -$283K -18,732 Closed
JMPWA
107
JP Morgan Private Wealth Advisors
California
– -$282K -18,628 Closed
DC
108
Diametric Capital
Massachusetts
– -$281K -18,573 Closed
BNP Paribas Financial Markets
109
BNP Paribas Financial Markets
France
– -$255K -16,855 Closed
AG
110
Algert Global
California
– -$231K -15,269 Closed
WCMNY
111
Westchester Capital Management (New York)
New York
– -$227K -15,000 Closed
Susquehanna International Group
112
Susquehanna International Group
Pennsylvania
– -$225K -14,877 Closed
GC
113
Guggenheim Capital
Illinois
– -$212K -14,020 Closed
Jane Street
114
Jane Street
New York
– -$197K -13,041 Closed
ASRS
115
Arizona State Retirement System
Arizona
– -$180K -11,892 Closed
WAM
116
Wolverine Asset Management
Illinois
– -$179K -11,841 Closed
IWC
117
Integrated Wealth Concepts
Massachusetts
– -$169K -11,185 Closed
GAM
118
Gotham Asset Management
New York
– -$168K -11,106 Closed
CCM
119
Chicago Capital Management
Illinois
– -$157K -10,348 Closed
Public Employees Retirement Association of Colorado
120
Public Employees Retirement Association of Colorado
Colorado
– -$124K -8,192 Closed
AB
121
Amalgamated Bank
New York
– -$112K -7,370 Closed
Lazard Asset Management
122
Lazard Asset Management
New York
– -$109K -7,248 Closed
Royal Bank of Canada
123
Royal Bank of Canada
Ontario, Canada
– -$105K -6,923 Closed
Macquarie Group
124
Macquarie Group
Australia
– -$83K -5,100 Closed
Zurich Cantonal Bank
125
Zurich Cantonal Bank
Switzerland
– -$76K -5,030 Closed
2 3 4
5
6

AERI Hedge Fund Activity: Q4 2022 in Review

0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2022, worth a combined $0 — down 100% from $703M a quarter earlier.

Sellers outnumbered buyers: 153 funds closed out of AERI and 0 opened new positions — a net loss of 153 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deerfield Management, exiting entirely with an estimated $73.5M sold.

  • 0 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2022, down from 156 in Q3 2022.
  • Funds reported $0 of Aerie Pharmaceuticals stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Aerie Pharmaceuticals positions in Q4 2022 and 153 closed out, a net change of -153 holders.
  • The largest Aerie Pharmaceuticals seller in Q4 2022 was Deerfield Management, an estimated $73.5M sold.

Based on aggregated 13F filings for Q4 2022.